Maximum quantity allowed is 999
Please select the quantity
CAS RN: 172152-36-2 | Product Number: I1191
Ilaprazole
×
![]()
×
Purity: >98.0%(T)(HPLC)
Synonyms:
- 2-[[(4-Methoxy-3-methyl-2-pyridinyl)methyl]sulfinyl]-6-(1H-pyrrol-1-yl)-1H-benzimidazole
- 2-[[(4-Methoxy-3-methylpyridin-2-yl)methyl]sulfinyl]-6-(1H-pyrrol-1-yl)-1H-benzo[d]imidazole
Product Documents:
| Size | Unit Price | Shanghai | Tianjin | Japan* |
|---|---|---|---|---|
| 250MG |
¥590.00
|
4 | Contact Us | 8 |
| 1G |
¥1,570.00
|
1 | Contact Us | 16 |
* For order or inquiry, please contact
Our Authorized Distributors.
*TCI frequently reviews storage conditions to optimize them. Please note that the latest information on the storage temperature for the products is described on our website.
* To send your quote request for bulk quantities, please click on the "Request Bulk Quote" button. Please note that we cannot offer bulk quantities for some products.
| Product Number | I1191 |
| Purity / Analysis Method | >98.0%(T)(HPLC) |
| Molecular Formula / Molecular Weight | C__1__9H__1__8N__4O__2S = 366.44 |
| Physical State (20 deg.C) | Solid |
| Storage Temperature | Refrigerated (0-10°C) |
| Store Under Inert Gas | Store under inert gas |
| Condition to Avoid | Air Sensitive,Heat Sensitive |
| Packaging and Container | 1G-Glass Bottle with Plastic Insert (View image), 250MG-Glass Bottle with Plastic Insert (View image) |
| CAS RN | 172152-36-2 |
| Reaxys Registry Number | 8859737 |
| MDL Number | MFCD00942538 |
Specifications
| Appearance | White to Light yellow powder to crystal |
| Purity(HPLC) | min. 98.0 area% |
| Purity(Nonaqueous Titration) | min. 98.0 % |
| Melting point | 149.0 to 153.0 °C |
| NMR | confirm to structure |
Properties (reference)
| Melting Point | 151 °C |
GHS
Related Laws:
Transport Information:
| Customs Control Conditions (Q) |
Application
Ilaprazole: A Proton Pump Inhibitor with Superior Pharmacological Profile
Ilaprazole (IY-81149) is a proton pump inhibitor (PPI) used in the treatment of dyspepsia, peptic ulcer disease (PUD), gastroesophageal reflux disease (GERD) and duodenal ulcer in clinical.1,2) Compared with all other PPIs, ilaprazole has shown an extended plasma half-life, a metabolism not significantly influenced by CYP2C19 genetic polymorphism and similar safety.2) Ilaprazole can be used with clarithromycin [C2220] and amoxicillin [A2099] as a triple therapy regimen for eradicating Helicobacter pylori.3) In addition, there are reports that PPIs including ilaprazole suppresses cancer growth.4) (The product is for research purpose only.)
References
- 1) General pharmacology of IY-81149, a new proton pump inhibitor
- 2) Ilaprazole for the treatment of gastro-esophageal reflux (a review)
- 3) Pharmacokinetic drug interaction and safety after coadministration of clarithromycin, amoxicillin, and ilaprazole: a randomised, open-label, one-way crossover, two parallel sequences study
- 4) Proton pump inhibitor ilaprazole suppresses cancer growth by targeting T-cell-originated protein kinase.
- 5) Determination of Proton Pump Inhibitors by Spectrophotometric, Chromatographic and by Hyphenated Techniques: A Review
Product Documents (Note: Some products will not have analytical charts available.)
Safety Data Sheet (SDS)
Please select Language.
The requested SDS is not available.
Please Contact Us for more information.
Specifications
C of A & Other Certificates
Please enter Lot Number
Incorrect Lot Number. Please input only the 4-5 alphanumeric characters before the hyphen.
Sample C of A
This is a sample C of A and may not represent a recently manufactured lot of the product.
A sample C of A for this product is not available at this time.
Analytical Charts
Please enter Lot Number
Incorrect Lot Number. Please input only the 4-5 alphanumeric characters before the hyphen.
The requested analytical chart is not available. Sorry for the inconvenience.